0000000000515473

AUTHOR

G. Maniscalco

showing 4 related works from this author

Feasibility study for the measurement of πN transition distribution amplitudes at P¯ANDA in p¯p→J/ψπ0

2017

The exclusive charmonium production process in (P) over barp annihilation with an associated pi 0 meson (p) over barp -> J/psi pi(0) is studied in the framework of QCD collinear factorization. The feasibility of measuring this reaction through the J/psi -> e(+) e(-) decay channel with the AntiProton ANnihilation at DArmstadt ((P) over bar ANDA) experiment is investigated. Simulations on signal reconstruction efficiency as well as the background rejection from various sources including the (P) over barp -> pi(+)pi(-)pi(0) and (p) over barp -> J/psi pi(0)pi(0) reactions are performed with PANDAROOT, the simulation and analysis software framework of the (P) over bar ANDA experiment. It is show…

Quantum chromodynamicsPhysicsParticle physicsLuminosity (scattering theory)AnnihilationMeson010308 nuclear & particles physics7. Clean energy01 natural sciencesParticle identificationNuclear physicsFactorizationAntiproton0103 physical sciencesHigh Energy Physics::Experiment010306 general physicsBar (unit)Physical Review D
researchProduct

Study of doubly strange systems using stored antiprotons

2016

Bound nuclear systems with two units of strangeness are still poorly known despite their importance for many strong interaction phenomena. Stored antiprotons beams in the GeV range represent an unparalleled factory for various hyperon-antihyperon pairs. Their outstanding large production probability in antiproton collisions will open the floodgates for a series of new studies of systems which contain two or even more units of strangeness at the PANDA experiment at FAIR. For the first time, high resolution gamma-spectroscopy of doubly strange Lambda Lambda-hypernuclei will be performed, thus complementing measurements of ground state decays of Lambda Lambda-hypernuclei at J-PARC or possible …

Particle physicsNuclear and High Energy PhysicsCOLLISIONSStrong interactionNuclear TheoryhyperatomsAntiprotons; Hyperatoms; Hypernuclei; Strangeness; Nuclear and High Energy PhysicsEXCHANGE CURRENTSAntiprotonsStrangeness01 natural sciencesPartícules (Física nuclear)NONuclear physicsSubatomär fysikHypemucleistrangenessDECUPLET BARYONSELECTRIC QUADRUPOLE-MOMENTSHyperatoms0103 physical sciencesSubatomic PhysicsHypernuclei010306 general physicsNuclear ExperimentPhysicshypernucleiNUCLEI010308 nuclear & particles physicsHyperonStrangenessTransport theoryDOUBLE-LAMBDA-HYPERNUCLEIMODELOMEGAAntiprotonPhysics::Accelerator PhysicsHeavy ionHigh Energy Physics::ExperimentantiprotonsINTERMEDIATE ENERGIESEMULSIONNuclear Physics A
researchProduct

Prophylaxis of venous thromboembolism in elderly patients with multimorbidity

2013

none 327 si Pharmacological thromboprophylaxis (TP) is known to reduce venous thromboembolism (VTE) in medical inpatients, but the criteria for risk-driven prescription, safety and impact on mortality are still debated. We analyze data on elderly patients with multimorbidities admitted in the year 2010 to the Italian internal medicine wards participating in the REPOSI registry to investigate the rate of TP during the hospital stay, and analyze the factors that are related to its prescription. Multivariate logistic regression, area under the ROC curve and CART analysis were performed to look for independent predictors of TP prescription. Association between TP and VTE, bleeding and death in …

MaleTVPSettore MED/09 - Medicina InternaComorbidityLogistic regressionFondaparinuxVENOUS THROMBOEMBOLISM; THROMBOPROPHYLAXIS; Medical PatientsMedical patients; Thromboprophylaxis; Venous thromboembolism; Aged; Aged 80 and over; Area Under Curve; Comorbidity; Female; Hospital Mortality; Hospitalization; Humans; Logistic Models; Male; Propensity Score; Venous Thromboembolism; Internal Medicine; Emergency MedicineThromboprophylaxis Venous thromboembolism Medical patients80 and overHospital MortalityAged 80 and overSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheMedical patients; Thromboprophylaxis; Venous thromboembolism; Aged; Aged; 80 and over; Area Under Curve; Comorbidity; Female; Hospital Mortality; Hospitalization; Humans; Logistic Models; Male; Propensity Score; Venous Thromboembolism; Internal Medicine; Emergency Medicineprophylaxis; venous thromboembolism; elderlyHospitalizationArea Under CurveEmergency MedicineFemaleprophylaxismedicine.drugVenous thromboembolismmedicine.medical_specialtyThromboprophylaxis; Venous thromboembolismmultimorbidityBarthel indexvenous thromboembolismMEDLINEMedical patients; Thromboprophylaxis; Venous thromboembolism; Aged; Aged 80 and over; Area Under Curve; Comorbidity; Female; Hospital Mortality; Hospitalization; Humans; Logistic Models; Male; Propensity Score; Venous Thromboembolism; Emergency Medicine; Internal Medicineelderly patientselderlyMedical patientsInternal medicineInternal MedicinemedicineHumansMedical prescriptionprophylaxis; venous thromboembolism; elderly patientsPropensity ScoreIntensive care medicineThromboprophylaxisAgedbusiness.industryprophylaxiMedical patients; Thromboprophylaxis; Venous thromboembolismprophylaxis; Venous thromboembolism; Elderly; multimorbidity; medical patients; thromboprophylaxismedicine.diseaseComorbidityLogistic ModelsPropensity score matchingbusinessVenous thromboembolism
researchProduct

IOL Multifocali di II e III generazione: performance visiva e capacità di lettura

2011

Multifocal IOL reading speed contrast sensitivity
researchProduct